tert-Butyl 3-oxoazetidine-1-carboxylate | CAS:398489-26-4

We serve tert-Butyl 3-oxoazetidine-1-carboxylate CAS:398489-26-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
tert-Butyl 3-oxoazetidine-1-carboxylate

Chemical Name:tert-Butyl 3-oxoazetidine-1-carboxylate
CAS.NO:398489-26-4
Synonyms:tert-Butyl 3-oxoazetidine-1-carboxylate
3-Oxoazetidine-1-carboxylic Acid tert-Butyl Ester
N-Boc-3-oxoazetidine
1-(tert-Butoxycarbonyl)-3-azetidinone
1-BOC-3-Azetidinone
1-N-Boc-3-azetidinone
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 251.3±33.0 °C at 760 mmHg
Melting Point 49-52ºC
Molecular Formula C8H13NO3
Molecular Weight 171.194
Flash Point 105.8±25.4 °C
 
Specification:
Appearance:Off-white crystals
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Baricitinib.



Contact us for information like tert-Butyl 3-oxoazetidine-1-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-N-Boc-3-azetidinone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Oxoazetidine-1-carboxylic Acid tert-Butyl Ester Use and application,1-(tert-Butoxycarbonyl)-3-azetidinone technical grade,usp/ep/jp grade.


Related News: Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations.methyl 4-(butanoylamino)-3-methylbenzoate manufacturer South Korea said on Sunday that it would deny entry to any foreigners who have traveled to Wuhan and surrounding Hubei Province in China in the past 14 days.3-Bromo-5-fluorobenzoic acid supplier Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis.1-Bromo-4-chloronaphthalene vendor Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis.Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.